European Medicines Agency's Panel Supports Approval Of Novartis' Kisqali In Patients With Early-Breast Cancer
European Medicines Agency's Panel Supports Approval Of Novartis' Kisqali In Patients With Early-Breast Cancer On Friday, Novartis AG (NYSE:NVS) announced that the European Medicines Agency’s (EMA)...